Publication | Closed Access
Leflunomide use during the first 33 months after food and drug administration approval: Experience with a national cohort of 3,325 patients
48
Citations
17
References
2003
Year
LEF is relatively safe in clinical practice. The VA's national databases provide an excellent, inexpensive resource for postmarketing evaluation of rheumatologic medications.
| Year | Citations | |
|---|---|---|
Page 1
Page 1